About Growth hormone secretagogue receptor type 1
Growth hormone secretagogue receptor type 1 (GHSR) is a protein
from Homo sapiens identified by UniProt accession
Q92847, 366 residues long.
MolForge cross-references it against 0 known binders and
339 disease associations.
Target properties
| Protein name | Growth hormone secretagogue receptor type 1 |
| UniProt accession | Q92847 |
| Gene | GHSR |
| Organism | Homo sapiens |
| Length | 366 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (4)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (339)
Diseases linked to this target (Open Targets).
- short stature due to GHSR deficiency · score 0.70
- body height · score 0.57
- lean body mass · score 0.53
- IGF-1 measurement · score 0.50
- forced expiratory volume · score 0.44
- refractive error measurement · score 0.44
- appendicular lean mass · score 0.40
- whole body water mass · score 0.40
- leukocyte count · score 0.39
- body weight · score 0.39
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q92847-F1 | alphafold | PREDICTED | 81.60 | — |
Amino-acid sequence (366 residues)
MWNATPSEEP GFNLTLADLD WDASPGNDSL GDELLQLFPA PLLAGVTATC VALFVVGIAG NLLTMLVVSR FRELRTTTNL YLSSMAFSDL LIFLCMPLDL VRLWQYRPWN FGDLLCKLFQ FVSESCTYAT VLTITALSVE RYFAICFPLR AKVVVTKGRV KLVIFVIWAV AFCSAGPIFV LVGVEHENGT DPWDTNECRP TEFAVRSGLL TVMVWVSSIF FFLPVFCLTV LYSLIGRKLW RRRRGDAVVG ASLRDQNHKQ TVKMLAVVVF AFILCWLPFH VGRYLFSKSF EPGSLEIAQI SQYCNLVSFV LFYLSAAINP ILYNIMSKKY RVAVFRLLGF EPFSQRKLST LKDESSRAWT ESSINT
Explore Growth hormone secretagogue receptor type 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets